Diversified Trust CO Assembly Biosciences, Inc. Transaction History

Diversified Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$2.13 - $3.46 $34,501 - $56,045	-16,198 Closed	0 $0
Q3 2021 Jan 13, 2022	SELL	$3.14 - $3.9 $44,431 - $55,185	-14,150 Reduced 46.63%	16,198 $56,000
Q2 2021 Jul 20, 2021	BUY	$3.8 - $4.56 $34,580 - $41,496	9,100 Added 42.83%	30,348 $118,000
Q1 2021 May 10, 2021	SELL	$4.33 - $6.63 $1,290 - $1,975	-298 Reduced 1.38%	21,248 $98,000
Q4 2020 Jan 08, 2021	BUY	$4.87 - $17.29 $104,929 - $372,530	21,546 New	21,546 $130,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $714M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.